IP Verse

The Regents Of The University Of California patent opposition analysis

Latest patents of The Regents Of The University Of California opposed by its competitors

The following table provides an overview of the latest patents of The Regents Of The University Of California that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3250693Dec 20, 2023Protein Delivery In Primary Hematopoietic Cells1
EP3495822Dec 20, 2023Method For Assessing Acute Myocardial Infarction Based On Highly Sensitive Analysis Of Cardiac Troponin1
EP3597749Jul 26, 2023Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription3
EP2906696Dec 14, 2022Methods For Modulating C9Orf72 Expression2
EP1793855Jan 19, 2022Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease1
EP3615667Aug 11, 2021Microorganisms And Methods For Producing Cannabinoids And Cannabinoid Derivatives2
EP3604339Mar 10, 2021Therapeutic Antibodies Against Ror-1 Protein And Methods For Use Of Same1
EP2328553Jun 10, 2020Corticosteroids For The Treatment Of Inflammatory Diseases Of The Gastrointestinal Tract1
EP2535044Dec 18, 2019Enterically Coated Cysteamine, Cystamine And Derivatives Thereof1
EP2709672Dec 18, 2019Compositions And Methods For Treating Retinal Diseases1

Top competitors of The Regents Of The University Of California